1. Parkin DM, Whelan SL, Ferlay J, Storm H. Cancer Incidence in Five Continents, Vols. I-VIII. International Agency for Research on Cancer, Cancer Base No. 7, Lyon, 2005; CANCERMondial: http://www-dep.iarc.fr.
2. DeVita VT, Hellman S, Rosenberg SA. Cancer: Principles and Practice of Oncology, 7th ed. Philadelphia: Lippincott Williams & Wilkins, 2004.
3. Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 2003; 348(10): 919-32.
4. de la Chapelle A. Genetic predisposition to colo­rectal cancer. Nature Rev Cancer 2004; 4(10): 769-780.
5. Glatt H, Boeing H, Engelke CE, Ma L, Kuhlow A, Pabel U, Pomplun D, Teubner W, Meinl W. Human cyto­solic sulphotransferases: genetics, characteristics, toxicological aspects. Mutat Res 2001; 482(1-2): 27-40.
6. Chou HC, Lang NP, Kadlubar FF. Metabolic activation of N-hydroxy arylamines and N-hydroxy hetero­cyclic amines by human sulfotransferase(s). Cancer Res 1995; 55(3): 525-529.
7. Glatt H, Pabel U, Meinl W, Frederiksen H, Frandsen H, Muckel E. Bioactivation of the heterocyclic aromatic amine 2-amino-3-methyl-9H-pyrido [2,3-b] indole (MeA[a]C) in recombinant test systems expressing human xenobiotic-metabolizing enzymes. Carcinogenesis 2004; 25(5): 801-807.
8. Zou JY, Petney R, Roth JA. Immunohistochemical detection of phenol sulfotransferase-containing neurons in human brain. J Neurochem 1990; 55(4): 1154-1158.
9. Hume R, Barker EV, Coughtrie MW. Differential expression and immunohistochemical localization of the phenol and hydroxysteroid sulphotransferase enzyme families in the developing lung. Histochem Cell Biol 1996; 105(2): 147-152.
10. Harris RM, Picton R, Singh S, Waring RH. Activity of phenolsulfotransferases in the human gastrointestinal tract. Life Sci 2000; 67(17): 2051-2057.
11. Dooley TP, Obermoeller RD, Leiter EH, Chapman HD, Falany CN, Deng Z, Siciliano MJ. Mapping of the phenol sulfotransferase gene (STP) to human chromosome 16p12.1-p11.2 and to mouse chromosome 7. Ge­nomics 1993; 18(2): 440-443.
12. Ozawa S, Tang YM, Yamazoe Y, Kato R, Lang NP, Kadlubar FF. Genetic polymorphisms in human liver phenol sulfotransferases involved in the bioactivation of N-hydroxy derivatives of carcinogenic arylamines and heterocyclic amines. Chem Biol Interact 1998; 9(1-3): 237-248.
13. Bamber DE, Fryer AA, Strange RC, Elder JB, Deakin M, Rajagopal R, Fawole A, Gilissen RA, Campbell FC, Coughtrie MW. Phenol sulphotransferase SULT1A1*1 genotype is associated with reduced risk of colorectal cancer. Pharmacogenetics 2001; 11(8): 679-685.
14. Sachse C, Smith G, Wilkie MJ, Barrett JH, Waxman R, Sullivan F, Forman D, Bishop DT, Wolf CR. A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer. Carcino­genesis 2002; 23(11): 1839-1849.
15. Wong CF, Liyou N, Leggett B, Young J, Johnson A, McManus ME. Association of the SULT1A1 R213H polymorphism with colorectal cancer. Clin Exp Pharmacol Physiol 2002; 29(9): 754-758.
16. Peng CT, Chen JC, Yeh KT, Wang YF, Hou MF, Lee TP, Shih MC, Chang JY, Chang JG. The relationship among the polymorphisms of SULT1A1, 1A2 and different types of cancers in Taiwanese. Int J Mol Med 2003; 11(1): 85-89.
17. Nowell S, Coles B, Sinha R, MacLeod S, Luke Ratnasinghe D, Stotts C, Kadlubar F, Ambrosone C, Lang N. Analysis of total meat intake and exposure to individual heterocyclic amines in a case-control study of colo­rectal cancer: contribution of metabolic variation to risk. Mutat Res 2003; 506-507: 175-185.
18. Moreno V, Glatt H, Guino E, Fisher E, Meinl W, Navarro M, Badosa JM, Boeing H, Bellvitge Colorectal Cancer Study Group. Polymorphisms in sulfotransferases SULT1A1 and SULT1A2are not related to colorectal cancer. Int J Cancer 2005; 113(4): 683-686.
19. Coughtrie MW, Gilissen RA, Shek B, Strange RC, Fryer AA, Jones PW, Bamber DE. Phenol sulpho­transferase SULT1A1 polymorphism: molecular diagnosis and allele frequencies in Caucasian and African populations. Biochem J 1999; 337(Pt 1): 45-49.
20. Carlini E, Raftogianis R, Wood T. Sulfation phar­macogenetics: SULT1A1 and SULT1A2 allele frequencies in Caucasian, Chinese and African-American subjects. Pharmacogenetics 2001; 11(1): 57-68.
21. Stefanovska A-M, Jasar D, Zografski G, Josifovski T, Panovski T, Jankova R, Spiroski M, Efremov GD, Dimovski AJ. TbR-I(6A) Polymorphism is not a tumor susceptibility allele in Macedonian colorectal cancer patients. Cancer Res 2001; 61(22): 8351-8352.
22. Stefanovska A-M, Efremov GD, Jasar D, Zografski G, Josifovski T, Panovski T, Dimovski AJ. G480A Polymorphism in the Cyclin D1 gene in colorectal cancer. Balkan J Med Genet 2002; 5(1&2): 27-30.
23. Chan AO, Soliman AS, Zhang Q, Rashid A, Bedeir A, Houlihan PS, Mokhtar N, Al-Masri N, Ozbek U, Yaghan R, Kandilci A, Omar S, Kapran Y, Dizdaroglu F, Bondy ML, Amos CI, Issa JP, Levin B, Hamilton SR. Differing DNA methylation patterns and gene mutation frequencies in colorectal carcinomas from Middle Eastern countries. Clin Cancer Res 2005; 11(23): 8281-8287.
24. Di Leo A, Messa C, Cavallini A, Linsalata M. Estrogens and colorectal cancer. Curr Drug Targets Immune Endocr Metabol Disord 2001; 1(1): 1-12.
25. Mandelson MT, Miglioretti D, Newcomb PA, Harrison R, Potter JD. Hormone replacement therapy in relation to survival in women diagnosed with colon cancer. Cancer Causes Control 2003; 14(10): 979-984.
26. Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, Hubbell FA, Ascensao J, Rodabough RJ, Rosenberg CA, Taylor VM, Harris R, Chen C, Adams-Campbell LL, White E, Women's Health Initiative Investigators. Estrogen plus progestin and colorectal cancer in postmeno­pausal women. N Engl J Med 2004; 350(10): 991-1004.